Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/ITI-007> ?p ?o }
- ITI-007 abstract "ITI-007 is an investigational atypical antipsychotic which is currently under development by Intra-Cellular Therapies, licensed from Bristol-Myers Squibb, for the treatment of schizophrenia. It is also being developed by Intra-Cellular Therapies for the treatment of bipolar disorder, depression, and sleep and behavioral disturbance in dementia, autism, and other neuropsychiatric disorders. As of May 2015, ITI-007 is in phase III clinical trials for schizophrenia.".
- ITI-007 iupacName "4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1 ,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)-butan-1-one".
- ITI-007 pubchem "9821941".
- ITI-007 thumbnail ITI-007_structure.png?width=300.
- ITI-007 wikiPageExternalLink iti-007.html.
- ITI-007 wikiPageExternalLink product-pipeline.html.
- ITI-007 wikiPageID "46746893".
- ITI-007 wikiPageLength "10969".
- ITI-007 wikiPageOutDegree "81".
- ITI-007 wikiPageRevisionID "674583102".
- ITI-007 wikiPageWikiLink 5-HT2A_receptor.
- ITI-007 wikiPageWikiLink 5-HT2B_receptor.
- ITI-007 wikiPageWikiLink 5-HT2C_receptor.
- ITI-007 wikiPageWikiLink Affinity_(pharmacology).
- ITI-007 wikiPageWikiLink Akathisia.
- ITI-007 wikiPageWikiLink Alpha-1A_adrenergic_receptor.
- ITI-007 wikiPageWikiLink Alpha-1B_adrenergic_receptor.
- ITI-007 wikiPageWikiLink Aripiprazole.
- ITI-007 wikiPageWikiLink Atypical_antipsychotic.
- ITI-007 wikiPageWikiLink Autism.
- ITI-007 wikiPageWikiLink Behavioral_disturbance.
- ITI-007 wikiPageWikiLink Bifeprunox.
- ITI-007 wikiPageWikiLink Bipolar_disorder.
- ITI-007 wikiPageWikiLink Blonanserin.
- ITI-007 wikiPageWikiLink Brexpiprazole.
- ITI-007 wikiPageWikiLink Bristol-Myers_Squibb.
- ITI-007 wikiPageWikiLink Cardiovascular_disease.
- ITI-007 wikiPageWikiLink Cardiovascular_function.
- ITI-007 wikiPageWikiLink Cardiovascular_physiology.
- ITI-007 wikiPageWikiLink Cariprazine.
- ITI-007 wikiPageWikiLink Catalepsy.
- ITI-007 wikiPageWikiLink Category:5-HT2A_antagonists.
- ITI-007 wikiPageWikiLink Category:Atypical_antipsychotics.
- ITI-007 wikiPageWikiLink Category:D2-receptor_agonists.
- ITI-007 wikiPageWikiLink Category:D2_antagonists.
- ITI-007 wikiPageWikiLink Category:Organofluorides.
- ITI-007 wikiPageWikiLink Category:Quinoxalines.
- ITI-007 wikiPageWikiLink Category:Serotonin_reuptake_inhibitors.
- ITI-007 wikiPageWikiLink Category:Sulfonates.
- ITI-007 wikiPageWikiLink Chemical_synapse.
- ITI-007 wikiPageWikiLink Cholesterol.
- ITI-007 wikiPageWikiLink Clinical_trial.
- ITI-007 wikiPageWikiLink Comorbidity.
- ITI-007 wikiPageWikiLink D1_receptor.
- ITI-007 wikiPageWikiLink D2_receptor.
- ITI-007 wikiPageWikiLink D4_receptor.
- ITI-007 wikiPageWikiLink Dementia.
- ITI-007 wikiPageWikiLink Depression_(mood).
- ITI-007 wikiPageWikiLink Diabetes.
- ITI-007 wikiPageWikiLink Diabetes_mellitus.
- ITI-007 wikiPageWikiLink Dopamine.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D1.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D2.
- ITI-007 wikiPageWikiLink Dopamine_receptor_D4.
- ITI-007 wikiPageWikiLink Drug-induced_QT_prolongation.
- ITI-007 wikiPageWikiLink Emotional_and_behavioral_disorders.
- ITI-007 wikiPageWikiLink Extrapyramidal_symptom.
- ITI-007 wikiPageWikiLink Extrapyramidal_symptoms.
- ITI-007 wikiPageWikiLink Glucose.
- ITI-007 wikiPageWikiLink H1_receptor.
- ITI-007 wikiPageWikiLink Haloperidol.
- ITI-007 wikiPageWikiLink Heart_rate.
- ITI-007 wikiPageWikiLink Histamine_H1_receptor.
- ITI-007 wikiPageWikiLink Insulin.
- ITI-007 wikiPageWikiLink Intra-Cellular_Therapies.
- ITI-007 wikiPageWikiLink Ligand_(biochemistry).
- ITI-007 wikiPageWikiLink Lurasidone.
- ITI-007 wikiPageWikiLink Major_depressive_disorder.
- ITI-007 wikiPageWikiLink Mechanism_of_action.
- ITI-007 wikiPageWikiLink Mental_disorder.
- ITI-007 wikiPageWikiLink Metabolism.
- ITI-007 wikiPageWikiLink Muscarinic_acetylcholine_receptor.
- ITI-007 wikiPageWikiLink Neurotransmission.
- ITI-007 wikiPageWikiLink Olanzapine.
- ITI-007 wikiPageWikiLink Partial_agonist.
- ITI-007 wikiPageWikiLink Pharmacovigilance.
- ITI-007 wikiPageWikiLink Phases_of_clinical_research.
- ITI-007 wikiPageWikiLink Placebo.
- ITI-007 wikiPageWikiLink Postsynaptic.
- ITI-007 wikiPageWikiLink Presynaptic.
- ITI-007 wikiPageWikiLink Prolactin.
- ITI-007 wikiPageWikiLink Psychosis.
- ITI-007 wikiPageWikiLink QTc_prolongation.
- ITI-007 wikiPageWikiLink RP5063.
- ITI-007 wikiPageWikiLink Receptor_antagonist.
- ITI-007 wikiPageWikiLink Risperidone.
- ITI-007 wikiPageWikiLink Schizophrenia.
- ITI-007 wikiPageWikiLink Sedation.
- ITI-007 wikiPageWikiLink Serotonin_reuptake_inhibitor.
- ITI-007 wikiPageWikiLink Serotonin_transporter.
- ITI-007 wikiPageWikiLink Sleep_disorder.
- ITI-007 wikiPageWikiLink Sleep_disturbance.
- ITI-007 wikiPageWikiLink Social_function.
- ITI-007 wikiPageWikiLink Somnolence.
- ITI-007 wikiPageWikiLink Striatum.
- ITI-007 wikiPageWikiLink Structural_functionalism.
- ITI-007 wikiPageWikiLink Suicidal_behavior.
- ITI-007 wikiPageWikiLink Suicidal_ideation.
- ITI-007 wikiPageWikiLink Suicide.
- ITI-007 wikiPageWikiLink Tolerability.